Art Van Zee
Biographic Data
| ID | 6069985 |
|---|---|
| NAME | Art Van Zee |
| GIVEN NAMES | Art |
| FAMILY NAME | Van Zee |
| SIGNATURE | VAN ZEE A |
| AFFILIATIONS | Art Van Zee is with the St. Charles Clinic, Stone Mountain Health Services, St. Charles, VA. David Fiellin is with the Departments of Medicine and Emergency Medicine and the Program in Addiction Medicine, Yale University School of Medicine, and the Department of Health Policy and Management and the Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT. |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 50 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2009 |
| LATEST PUBLICATION YEAR | 2019 |
| H-INDEX | 1 |
Proliferation of Cash-Only Buprenorphine Treatment Clinics
"Proliferation of Cash-Only Buprenorphine Treatment Clinics: A Threat to the Nation's Response to the Opioid Crisis." , 109(3), pp. 393–394
The Promotion and Marketing of OxyContin
I focus on issues surrounding the promotion and marketing of controlled drugs and their regulatory oversight. Compared with noncontrolled drugs, controlled drugs, with their potential for abuse and diversion, pose different public health risks when they are overpromoted and highly prescribed. An in-depth analysis of the promotion and marketing of OxyContin illustrates some of the associated issues. Modifications of the promotion and marketing of …
The Promotion and Marketing of OxyContin
I focus on issues surrounding the promotion and marketing of controlled drugs and their regulatory oversight. Compared with noncontrolled drugs, controlled drugs, with their potential for abuse and diversion, pose different public health risks when they are overpromoted and highly prescribed. An in-depth analysis of the promotion and marketing of OxyContin illustrates some of the associated issues. Modifications of the promotion and marketing of …
Proliferation of Cash-Only Buprenorphine Treatment Clinics
"Proliferation of Cash-Only Buprenorphine Treatment Clinics: A Threat to the Nation's Response to the Opioid Crisis." , 109(3), pp. 393–394
The Promotion and Marketing of OxyContin
I focus on issues surrounding the promotion and marketing of controlled drugs and their regulatory oversight. Compared with noncontrolled drugs, controlled drugs, with their potential for abuse and diversion, pose different public health risks when they are overpromoted and highly prescribed. An in-depth analysis of the promotion and marketing of OxyContin illustrates some of the associated issues. Modifications of the promotion and marketing of …
Proliferation of Cash-Only Buprenorphine Treatment Clinics
"Proliferation of Cash-Only Buprenorphine Treatment Clinics: A Threat to the Nation's Response to the Opioid Crisis." , 109(3), pp. 393–394
Business (2 works) · Medicine (2 works) · Buprenorphine (1 works) · Cash (1 works) · Environmental health (1 works) · Finance (1 works) · Finance (1 works) · Food and drug administration (1 works) · Health promotion (1 works) · Health Systems, Economic Evaluations, Quality of Life (1 works)